Evidence map›Paper›PMID 33437803›Full record

ArticleAnnals of translational medicine2020

A study protocol for expanding the screening interval of endoscopic screening for gastric cancer based on individual risks: prospective cohort study of gastric cancer screening.

Chisato Hamashima, Kenichi Yoshimura, Akira Fukao

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. The index endoscopic characteristics associated with gastric neoplasms in serial screening of upper gastrointestinal endoscopy.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2025
    Article
  4. Article
  5. Chronic Atrophic Gastritis and Intestinal Metaplasia: A Latin American Perspective.The Korean journal of helicobacter and upper gastrointestinal research · 2024
    Review
  6. Review
  7. Gastric Cancer Screening in Japan: A Narrative Review.Journal of clinical medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Chisato HamashimaHealth Policy Section, Department of Nursing, Faculty of Medical Technology, Teikyo University, Tokyo, Japan.
Kenichi YoshimuraFuture Medical Center, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Akira FukaoMiyagi Cancer Association, Sendai, Japan.
Hiroshima University Hospital · JPJapan Cancer Society · JPTeikyo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Japanese government has recommended a 2-year endoscopic screening interval for gastric cancer. However, insufficient resources have constrained participation in endoscopic screening for gastric cancer. One way to avoid endoscopic screening harms and provide equal access is to define the appropriate screening interval.

methodsTo expand screening interval from more than 2 years for low-risk group, a single-arm cohort of endoscopic screening started. At the baseline screening, the participants underwent endoscopic screening for gastric cancer, DISCUSSION: To reduce mortality from gastric cancer, a high participation rate of the target population is required. The screening interval of endoscopic screening can be changed if the individual risks for

trial registrationUMIN000025839 (University Hospital Medical Information Network, Japan).

Indexed as

atrophic gastritiscancer screeningendoscopic screeningGastric cancerHelicobacter pyloriscreening interval

Identifiers

PMID33437803
PMCPMC7791261
OpenAlexW3110985410

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.